de Filippis, R. and Al Foysal, A. (2024) Case Report: The Role of Monoamine Oxidase Inhibitors in Treating Resistant Depression. Open Access Library Journal, 11, 1-12. doi: 10.4236/oalib.1112369 .
While Rejoyn is approved for depression, "it is not designed as a standalone treatment," says King; the approval is as a supplement to existing ... The strategy likely won’t be as effective in ...
Prompt recognition and effective treatment of depression are of critical importance for improving the cancer patient's quality of life. Despite the efficacy of antidepressant medications ...
A remote clinical trial involving more than 150 people has shown that an experimental treatment ... depression — which uses a swimming-cap-like device to gently stimulate the brain — can be ...
The cost of psilocybin-based treatment, priced at £1,200 ... is great potential for psilocybin to be a cost-effective therapy for severe depression – with higher quality impacts for the ...